Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system (CNS). Major deficits arise in MS patients due to an inability to repair damaged myelin sheaths following CNS insult, resulting in prolonged axonal exposure and neurodegeneration. The TAM receptors (Tyro3, Axl, and Mertk) have been implicated in MS susceptibility, demyelination and remyelination. Previously, we have shown that Tyro3 regulates developmental myelination and myelin thickness within the optic nerve and rostral region of the corpus callosum (CC) of adult mice. In this study we have verified and extended our previous findings via a comprehensive analysis of axonal ensheathment and myelin thickness in the CC of unchallenged mice, following demyelination and during myelin repair. We show that the loss of the Tyro3 receptor correlates with significantly thinner myelin sheaths in both unchallenged mice and during remyelination, particularly in larger caliber axons. The hypomyelinated phenotype observed in the absence of Tyro3 occurs independently of any influence upon oligodendrocyte precursor cell (OPC) maturation, or density of oligodendrocytes (OLs) or microglia. Rather, the primary effect of Tyro3 is upon the radial expansion of myelin. The loss of Tyro3 leads to a reduction in the number of myelin lamellae on axons, and is therefore most likely a key component of the regulatory mechanism by which oligodendrocytes match myelin production to axonal diameter.
g-ratios can significantly alter conduction velocities (Baraban, Mensch, & Lyons, 2016; Smith & Koles, 1970; Waxman, 1980) . Recent studies have implicated the receptor Tyro3 as a potential component of the molecular machinery that regulates axonal ensheathment and the radial expansion of myelin. Tyro3 is a member of the TAM family of receptors, a distinct receptor tyrosine kinase sub-family with relatively restricted expression profiles in the developed CNS (reviewed in Binder & Kilpatrick, 2009 ). Tyro3 is expressed by mature OLs, we have previously shown that in the absence of Tyro3, developmental myelination is delayed (Akkermann et al., 2017) .
Interestingly, while the density of total myelinated axons normalizes with maturity in Tyro3 deficient mice, myelin thickness does not and these mice consistently display thinner myelin than their WT counterparts; a phenotype also observed in the peripheral nervous system (Akkermann et al., 2017; Miyamoto et al., 2015) .
Given these findings, we hypothesized that the hypomyelinated phenotype observed in the absence of Tyro3 would not only be present widely within the unchallenged adult CNS but would also be apparent during remyelination. Therefore we investigated the influence of the Tyro3 receptor on myelination, demyelination and myelin repair in the rostral and caudal regions of the CC using the cuprizone mouse model. We have verified our previous findings in the rostral region of unchallenged mice and extended these findings to the caudal CC, where Tyro3 also appears to regulate myelin thickness. We show that loss of Tyro3 is associated with an accelerated rate of loss of myelinated axons during cuprizone challenge and thinner myelin during remyelination. We found that while the loss of Tyro3 results in a hypomyelinated phenotype, it does so without influencing OPC maturation or OL/microglial densities. Rather, Tyro3 influences the radial expansion of myelin such that the loss of Tyro3 leads to a reduction in the number of myelin lamellae on axons, and is therefore most likely a key component of the regulatory mechanism by which OLs match myelin production to axonal diameter.
| MATERIALS AND METHODS

| Animals
Tyro3
−/− C57Bl/6 mice were a gift from Prof. Greg Lemke (Salk Institute of Biological Studies, La Jolla, CA) (Lu et al., 1999) . Mice were previously fully backcrossed onto the C57Bl/6 background and maintained in a specific-pathogen-free environment during all breeding and experimentation (Akkermann et al., 2017) . All animal experiments were conducted according National Health and Medical Research Council Guidelines and approved by our institutional Animal Ethics Committee.
| Induction of demyelination/remyelination
Demyelination was induced by feeding 8-to 10-week-old mice powdered feed (Barastoc, Pakenham, Victoria, Australia) containing 0.2%
(w/w) cuprizone (bis-cyclohexanone oxaldihydrazone) for 3 weeks, as previously described (Binder et al., 2008) . Remyelination cohorts were treated with 0.2% (w/w) cuprizone for 5 weeks and then returned to regular mouse chow to allow remyelination for either 0, 2, 4, or 10 weeks, as previously described (Binder et al., 2011 To quantify myelin lamellae, high power TEM (50,000-200,000× magnification) was used on the same tissue as above. At least 50 myelinated axons per mouse (n = 3/group) were captured, ImageJ was used to quantify myelin lamellae and fibre diameter for each axon. 
| Immunohistochemical analysis
| Statistical analyses
All statistical analyses were performed using GraphPad PRISM 7 (GraphPad, version 7.0c, San Diego, CA). Differences between genotypes at a single time point were assessed using student's t tests. Differences between grouped data (genotypes and multiple time points)
were assessed using a two-way analysis of variance (ANOVA), followed by Holm-Sidak's multiple comparisons post hoc tests. Differences between myelin thickness/myelin lamellae quantity and axon diameter were assessed using linear regression. A p-value of < .05 was considered statistically significant.
3 | RESULTS
| Myelin thickness and myelin wrap number in the CC decrease in the absence of Tyro3
We have previously shown that the loss of Tyro3 leads to a reduction in the thickness of myelin in both the optic nerve and the rostral CC of unchallenged adult mice (Akkermann et al., 2017) . We sought to validate and extend these findings to other white matter regions by determining whether the hypomyelinated phenotype seen in Tyro3 −/− mice was also apparent in the caudal CC.
We used electron microscopy to quantify the number of myelinated axons in both the rostral and caudal regions of the CC of both WT and Tyro3 deficient mice (Figure 1a, b respectively; student's t test, p = .8).
In order to assess the influence of the Tyro3 receptor on myelin thickness we performed a morphometric analysis of the myelinated fibres, with the width of the myelin sheath plotted as a function of axon diameter. In both the rostral and caudal CC, the myelin sheath was on average approximately 10 nm thinner in Tyro3 deficient mice compared with WT counterparts (Figure 1e ,f; linear regression, p < .0001). We extended this analysis by assessing myelin ultrastructure under high power TEM. We found that the myelin membrane layers appeared appropriately compact in the Tyro3 −/− mice relative to WT controls (Figure 1g,h ). However, although myelin appeared normally compacted in the Tyro3 −/− mice, axons of equivalent diameter had, on average, one fewer myelin wrap compared with WT mice in the rostral CC ( Figure 1i ; linear regression, p = .0005). Additionally, we found that the Tyro3 −/− mice also had one fewer myelin wrap than WT counterparts within the caudal CC ( Figure 1j ; linear regression, p = .0007).
Taken together, these results confirm our previous data that Tyro3 is not essential for the initiation of myelination in the CNS. Instead, these data strongly support a central role for Tyro3 in controlling the number of myelin lamellae formed by an OL.
| The rate of demyelination is increased in the absence of Tyro3
We have previously shown that the rate of demyelination is accelerated in the rostral CC following the loss of the TAM receptor ligand, Gas6 (Binder et al., 2008) . In order to determine whether this effect was mediated through Tyro3, we subjected both Tyro3 −/− and WT mice to cuprizone for 3 weeks, inducing partial demyelination (Hiremath et al., 1997) . The number of myelinated axons was assessed in both the rostral and caudal regions of the CC using EM. Representative images of the rostral CC are shown in Figure 2a ,b.
In the rostral CC, we observed a seven-fold reduction in the total number of myelinated axons in Tyro3 thickness of nerve fibres were measured in both the rostral and caudal CC. Tyro3 deficient mice showed significantly thinner myelin in both the rostral and caudal segments of the CC compared with WT mice (p < .0001, p < .0001, rostral and caudal respectively). (g,h) Total myelin lamellae were quantified. Whilst Tyro3 deletion did not alter myelin compaction, an average of one fewer myelin lamella was observed in the absence of Tyro3 compared with WT axons of comparable diameter in both the rostral (i) and caudal (j) CC (p = .0005, p = .0007). Numerical results are presented as mean AE SEM, n = 3-4 mice per group, statistical significance was assessed using Student's t test for myelinated axon comparisons; linear regression was used for myelin thickness and lamellae comparisons. Scale bar = 2 μm Iba1 +ve microglia was altered in this region by co-staining for Mac-3.
We observed no significant difference in the percentage of microglia which were activated during demyelination in the rostral CC (96.13 AE 1.027 vs. 97.32 AE 0.8933% activated microglia/mm 2 in WT mice versus Tyro3 −/− mice respectively; student's t test, p = .4). Collectively, these observations strongly support a specific role of Tyro3 upon myelin integrity, unrelated to the survival or proliferation of OL lineage cells or the activation of microglia.
| Recovery from cuprizone-induced demyelination is altered in the absence of Tyro3
We had previously shown that not only is there an increase in the kinetics of demyelination, but that remyelination is also delayed in this context (Binder et al., 2011) . We therefore investigated whether this latter effect was contributed to by Tyro3. Given our data showing that loss of Tyro3 increases demyelination following 3 weeks of cuprizone, we chose a 5 week time-point of cuprizone challenge to provide equivalent nadir levels of demyelination across both WT and Tyro3 (f)
The rate of demyelination is increased in the absence of Tyro3. Demyelination was induced in WT and Tyro3 −/− mice (n = 3-4/group) by oral administration of cuprizone for 3 weeks. (a-d) To assess the effect of Tyro3 on demyelination, total myelinated axons/mm 2 and myelin thickness were quantified in both the rostral and caudal regions of the CC using EM. We observed a significant reduction in the number of myelinated axons within the rostral CC in the absence of Tyro3 compared with WT mice (e; p = .02) but not the caudal region (f; p = .4). Numerical results are presented as mean AE SEM, statistical significance was assessed using Student's t test. Scale bar = 5 μm (a)
(g) (f) (Figure 5f ; linear regression, p < .0001).
In order to determine whether the decrease in myelin thickness was due to a reduction in the number of myelin wraps, we used high power TEM to quantify the number of wraps in the rostral CC following 10 weeks of recovery. We found that axons from Tyro3 deficient mice had, on average, three fewer wraps than WT axons of equivalent diameter ( Figure 5g ; linear regression, p = .0402), with the effect particularly pronounced for larger axons (>1.5 μm) diameter. Therefore, consistent with our observations in developmental myelination, Tyro3
plays an important role in the re-establishment of appropriate myelin layering following myelin damage. Further, the effect of the loss of Tyro3 is heightened following myelin damage and subsequent recovery, with a greater difference in myelin thickness at all recovery timepoints compared with unchallenged mice.
| Tyro3 deletion does not alter the response of microglia or OL lineage cells to remyelination
We next examined the influence of Tyro3 on the cellular response during remyelination. To investigate this, WT and Tyro3 −/− animals were challenged with cuprizone for 5 weeks and assessed either immediately or after 4 weeks recovery. Then the densities of PDGFRα +ve /Olig2 +ve OPCs, CC1 +ve OLs and Iba1 +ve microglial cells from both the rostral and caudal CC were determined. Representative images are shown in Figure 6a . As expected, the proportions of all cell types examined were robustly altered during recovery from demyelination (Figure 6b-g ). However, consistent with our previous data from the demyelination phase, we found no evidence that the loss of Tyro3 influenced the proportion of OPCs, mature OLs or microglia in either the rostral or the caudal CC (two-way ANOVA, p > .05). Given the rapid recovery of myelin following cuprizone withdrawal, OPC and mature OL densities were also assessed following 2 weeks of remyelination. No significant differences were detected in either OPC or mature OL densities between the Tyro3 −/− and WT mice at the 2-week recovery time point in the rostral CC (Figure 6h , p = .12), indicating that the decreased myelin thickness observed during remyelination is not a result of altered oligodendroglial survival.
| DISCUSSION
This study has verified and extended upon, our previous findings which established that Tyro3 influences developmental myelination by regulating myelin thickness, an effect identified in the optic nerve and within the rostral CC (Akkermann et al., 2017) . This work has identified that Tyro3 also regulates the tempo of demyelination and the nature of myelin repair during and after exposure to cuprizone.
Further, Tyro3 does not regulate axonal ensheathment during remyelination, but rather, is involved in the fine-tuning of the radial expansion of myelin.
One striking and consistent feature of this study was the relationship of Tyro3 to the number of myelin layers around any given axon, both during normal development and during recovery from a demyelinating event. In unchallenged adult mice, the absence of Tyro3 led to a reduction of approximately 10 nm in myelin thickness equating with, on average, one fewer myelin wrap per axon in both the rostral and caudal CC. The reduction in the number of myelin lamellae was also observed following 10 weeks of recovery from cuprizone-induced demyelination, implying a cell-intrinsic defect in the ability of Tyro3 deficient OLs to appropriate quantities of myelin. Conversely, there was no alteration in the periodicity of the major dense-or intraperiodlines, unlike for example, the irregular myelin lamellae periodicity and compaction in proteolipid protein hemizygous mutant mice (Klugmann et al., 1997) . Taken together, these data suggest that the Tyro3 regulated, hypomyelinated phenotype was likely due to less overall myelin membrane deposition rather than a defect in myelin compaction.
Given the role we have demonstrated for Tyro3 in controlling the radial expansion of myelin, it is perhaps unsurprising that we found a What might be the molecular mechanism underpinning this effect? Surprisingly little is currently known about the mechanism by which OLs 'count' the number of wraps, thus matching myelin production to axonal diameter. The intracellular signaling molecules Erk1/2 and Akt have previously been shown to affect myelin thickness in the CNS (Flores et al., 2008; Ishii, Fyffe-Maricich, Furusho, Miller, & Bansal, 2012 ) and these pathways are potentially regulated via fibroblast growth factor receptor 2 (Furusho, Dupree, Nave, & Bansal, 2012; Furusho, Ishii, & Bansal, 2017) and also via Tyro3 (Akkermann et al., 2017) . However, it is not clear how this signalling is functionally linked to myelin production and the determination of how much myelin each axon receives. What is known is that the normal radial expansion of shown that Gas6 can enhance expression of MBP from both human
Loss of Tyro3 does not alter the rate of axon re-ensheathment during recovery from cuprizone-induced demyelination. Demyelination was induced in WT and Tyro3 −/− mice (n = 3-4/group) by oral administration of cuprizone for 5 weeks. Mice were then returned to normal feed for either 0, 2, 4, or 10 weeks to allow remyelination. To assess the effect of Tyro3 on remyelination, total myelinated axons/mm 2 and myelin thickness were quantified in both the rostral and caudal regions of the CC using EM at each time point. Representative images of WT (a-d) and Tyro3 −/− (e-h) from the rostral region of the CC are shown. No significant difference was observed in total myelinated axons between WT and Tyro3 −/− mice, in the rostral (i) or caudal (j) CC at 0 (p > .9, p = .8), 2 (p = .4, p > .9), 4 (p > .9, p = .3), or 10 (p > .9, p > .9) weeks recovery.
Numerical results are presented as mean AE SEM. Statistical significance was assessing using two-way ANOVA with Holm-Sidak's multiple comparisons, post hoc test. Scale bar =5 μm and rodent OLs (Binder et al., 2011; O'Guin et al., 2013) , and that this effect is lost when Tyro3 is absent (Akkermann et al., 2017) . A parsimonious view of these observations is that Gas6/Tyro3 is fundamentally implicated in calibrating optimal myelin thickness through activation of Erk1 signaling and in turn, MBP expression, although more extensive work will be required to confirm this hypothesis.
Although the molecular machinery implicated in regulating the extent of myelin production remains to be fully elucidated, our data strongly support a late-stage OL-specific mechanism. Consistent with our previous work examining developmental myelination, the hypomyelination phenotype observed in the absence of Tyro3 does not correlate with differences in OPC, OL or microglial densities, either during myelin injury or repair. This is consistent with other studies indicating that control of the radial expansion of myelin is independent of OPC proliferation and OL maturation (Flores et al., 2008; Ishii et al., 2012) . In addition, Tyro3 is predominantly expressed by mature
OLs rather than OPCs, and probably exerts its influence upon myelin production via a direct effect on mature OLs. However, given that Axon diameter (µm) Number of lamellae
Myelin thickness is reduced during recovery from cuprizone-induced demyelination in the absence of Tyro3. Demyelination was induced in WT and Tyro3 −/− mice (n = 3-4/group) by oral administration of cuprizone for 5 weeks. Mice were then returned to normal feed for either 0, 2, 4, or 10 weeks to allow remyelination to occur. Axon diameter and myelin thickness of nerve fibers were measured after 2 (a,d), 4 (b,e), and 10 (c,f ) weeks recovery in both the rostral (a-c) and caudal (d-f ) CC. In the rostral region, myelin was thinner in the absence of Tyro3 compared with WT mice at 2, 4, and 10 weeks recovery (a-c; all p-values < .0001). In the caudal region, when compared with WT mice, myelin was transiently thicker following 2 weeks of recovery (d; p = .02). This effect was not enduring, as following 4 and 10 weeks of recovery myelin was significantly thinner in the caudal CC of Tyro3 −/− mice than that of WT counterparts (e,f; p = .001, p < .0001, 4 and 10 weeks recovery respectively). (g) Fewer myelin lamellae were observed in the rostral CC following 10 weeks of recovery (p = .0402). Statistical significance was assessed using linear regression
(h) Tyro3 is expressed on a subset of neurons in the CNS, formal exclusion of an axonal contribution to the effect will require conditional deletion of Tyro3 from OLs (Prieto, O'Dell, Varnum, & Lai, 2007) .
Conversely, although Tyro3 appears to be a critical component of the mechanism by which OLs regulate myelin production, it appears to be dispensable for the initiation of myelination. We found no alteration in the number of myelinated axons in the CC in either unchallenged mice, or during myelin repair. In contrast, we have previously found that Gas6 deficient mice have fewer myelinated axons during recovery from cuprizone challenge, a result not reproduced in Tyro3 deficient mice (Binder et al., 2008) . This disparity clearly suggests that the delayed remyelination observed in the absence of Gas6 is due to reduced signaling via either Axl or Mertk. In support of this hypothesis, Ray et al. (2017) showed that remyelination was delayed in a Gas6 −/− Axl −/− double knockout (DKO) mice following cuprizoneinduced demyelination (Ray et al., 2017) . In addition, the authors observed increased expression of a number of inflammatory cytokines, strongly implicating microglial dysregulation as the main cause of delayed remyelination in the DKO mice. In totality, these data suggest a clear delineation between the roles of Axl and Tyro3 in recovery from myelin damage, whereby Gas6 signaling via Axl is critical for regulation of the inflammatory response of microglia, whilst signaling via Tyro3 is essential for the production of the appropriate amount of myelin by OLs. Less clear at present is the contribution of the other TAM receptor, Mertk, as its role in response to myelin damage has yet to be explicitly tested, something which warrants further attention in the future particularly given that MERTK is a known susceptibility gene for MS (Binder et al., 2016; Ma, Stankovich, Kilpatrick, Binder, & Field, 2010) . . Moreover, it has been observed that when myelin structure is restored to a thickness equivalent to undamaged myelin, for example when OPCs are derived from neural precursor cells in the SVZ, normal conductivity is restored (Remaud et al., 2017) . By implication, drugs that aim to promote the radial growth of myelin could have significant therapeutic potential in MS and related disorders of demyelination, enabling optimal saltatory conduction to be re-established.
Our results suggest that Tyro3 is a cogent therapeutic target to achieve this goal. However, It is important to recognize that myelin thickness is only one parameter that influences conduction velocity. It will therefore be important to confirm that conduction velocity can be improved through Tyro3 activation via direct empirical electrophysiological testing. 
